Department of Orthopaedic Surgery and Sports Medicine, University of South Carolina School of Medicine, Columbia, SC, USA.
J Am Acad Orthop Surg. 2013 Jan;21(1):51-60. doi: 10.5435/JAAOS-21-01-51.
Iliac crest bone graft has long been the standard adjunct used in spine fusion surgery. This graft provides osteogenic, osteoinductive, and osteoconductive elements that aid in creation of a fusion mass. However, morbidity associated with bone graft harvest has led surgeons to seek other potential adjuncts, including bone morphogenetic proteins, demineralized bone matrix, and graft expanders such as synthetic bone graft and allograft. Knowledge of fusion biology is required to understand the benefits and limitations of these agents, which promote fusion via one of four mechanisms: osteogenesis, osteoinduction, osteoconduction, and osteopromotion. Although bone morphogenetic proteins have shown a clear ability to aid in bone formation and successful fusion, recent concern regarding their safety has tempered enthusiasm regarding their use.
髂嵴骨移植一直是脊柱融合手术中标准的辅助手段。这种移植物提供了成骨、成骨诱导和骨传导的元素,有助于形成融合块。然而,与骨移植采集相关的发病率促使外科医生寻找其他潜在的辅助手段,包括骨形态发生蛋白、脱钙骨基质和移植物扩张器,如合成骨移植物和同种异体移植物。为了了解这些药物的益处和局限性,需要了解融合生物学,这些药物通过以下四种机制之一促进融合:成骨、成骨诱导、骨传导和骨促进。尽管骨形态发生蛋白已被证明具有明显的促进骨形成和成功融合的能力,但最近对其安全性的担忧降低了人们对其使用的热情。